Studies whether serum albumin predicts short-term death in acute coronary syndrome
Checks whether blood albumin levels can predict short-term death in adults with acute coronary syndrome.
Plain-language title generated from the registry record
Registry title: Serum Albumin in Acute Coronary Syndrome
Key facts
- Where
- Sohag, EgyptSee the site
Where in Egypt
- Faculty of Medicine, Sohag UniversitySohag, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sohag University
- Trial code
- NCT06727084
- Record updated
- 4 July 2025
- Original description
Our study aims to investigate the predictive value of serum albumin and short-term mortality in patients with Acute Coronary Syndrome (ACS)Read full original descriptionShow less
Predictive Value of Serum Albumin in Patients With Acute Coronary Syndrome
Our study aims to investigate the predictive value of serum albumin and short-term mortality in patients with Acute Coronary Syndrome (ACS)
Inclusion: Patients aged 18 years or older who were admitted to the emergency department or coronary care unit with a diagnosis of acute coronary syndrome (ACS) will be eligible for inclusion.
Exclusion: Patients with a history of chronic liver disease, nephrotic syndrome, or other conditions known to affect serum albumin levels; Patients receiving albumin infusions or other treatments that could potentially interfere with serum albumin levels; Patients with incomplete medical records or missing laboratory data; Patients who declined to participate in the study.